Oral dnaJP1 is a 14 amino acid sequence delivered once daily to rheumatoid arthritis (RA patients). Oral dnaJP1 has completed a 160 patient double-blind, placebo controlled Phase II
According to the company, this position will cover all group’s business development and acquisition activities as well as corporate planning, financial and economic evaluation of internal and external
The patented Falena device is a winged structure manufactured in titanium with a ‘C’ shaped spacer in Peek Optima to extend a rigidity and elasticity similar to bone
Under the brand name Preventa, Sensiotec will market and sell the medical device in the US and Canada under an exclusive worldwide license with its affiliate, Wireless 2000.
The Vitesse intracranial stent study for ischemic therapy (VISSIT) clinical trial is designed to include up to 250 patients who demonstrate ischemic symptoms attributable to stenosis of an
The acquisition of Ovation delivers on Lundbeck’s strategic goal to build a commercial infrastructure in the US. Following the transaction Lundbeck will have a diverse portfolio of marketed
Merck has reported positive data from new subgroup analyses of a Phase III study that compared the company’s integrase inhibitor Isentress to efavirenz, an antiretroviral prescribed for previously
During the third quarter the company increased product revenue by 19% while instituting programs, which are expected to reduce future cash operating expenses by about $2.6 million per
The scanner and associated software are used to detect and provide a quantitative measurement of HER2/neu, a protein that is measured in breast cancer patients in order to
According to Abbott, a key facet of CELL-DYN Emerald is its compact size – weighing just 9kg – as well as its intuitive software interface that allows for
Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.